| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
85,754 |
73,438 |
$3.03M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
44,786 |
40,211 |
$1.76M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
70,836 |
32,258 |
$949K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,008 |
6,826 |
$559K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
39,678 |
36,406 |
$534K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,452 |
6,193 |
$483K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,501 |
5,256 |
$449K |
| S8301 |
Infection control supplies, not otherwise specified |
53,737 |
46,340 |
$385K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,936 |
3,712 |
$289K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,476 |
5,228 |
$284K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
26,029 |
12,994 |
$273K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,918 |
5,420 |
$254K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
34,118 |
31,093 |
$218K |
| 99429 |
|
5,090 |
4,918 |
$163K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,602 |
1,571 |
$93K |
| 87807 |
|
7,429 |
6,852 |
$79K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
170 |
170 |
$65K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,796 |
5,117 |
$53K |
| 92567 |
|
3,487 |
3,330 |
$43K |
| 87428 |
|
754 |
719 |
$39K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
419 |
405 |
$34K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,267 |
1,199 |
$29K |
| 90461 |
|
3,732 |
2,990 |
$25K |
| 0002A |
|
625 |
598 |
$24K |
| 71046 |
Radiologic examination, chest; 2 views |
843 |
830 |
$22K |
| 99051 |
|
5,418 |
4,987 |
$22K |
| 94010 |
|
908 |
875 |
$21K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,331 |
1,225 |
$19K |
| 92587 |
|
952 |
925 |
$12K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
295 |
279 |
$12K |
| 0071A |
|
292 |
290 |
$12K |
| CP002 |
|
1,096 |
935 |
$11K |
| 96161 |
|
5,858 |
5,716 |
$10K |
| 0072A |
|
234 |
233 |
$9K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
302 |
295 |
$9K |
| 87486 |
|
170 |
170 |
$5K |
| 87581 |
|
169 |
169 |
$5K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
483 |
466 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
65 |
63 |
$5K |
| 97169 |
|
195 |
189 |
$4K |
| 99050 |
|
326 |
318 |
$4K |
| 81005 |
|
1,952 |
1,826 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
98 |
93 |
$3K |
| 83655 |
|
266 |
261 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
149 |
149 |
$2K |
| 70220 |
|
68 |
67 |
$2K |
| 74018 |
|
71 |
64 |
$2K |
| 0003A |
|
34 |
34 |
$1K |
| 99222 |
Initial hospital care, per day, moderate complexity |
12 |
12 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
87 |
82 |
$1K |
| 0081A |
|
21 |
21 |
$840.00 |
| 86580 |
|
93 |
89 |
$737.14 |
| 90686 |
|
4,859 |
4,799 |
$556.62 |
| 97802 |
|
13,601 |
13,280 |
$330.07 |
| 92551 |
|
64 |
61 |
$326.76 |
| 74019 |
|
12 |
12 |
$316.56 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
33 |
25 |
$303.18 |
| 90671 |
|
1,289 |
1,220 |
$171.00 |
| 90619 |
|
726 |
706 |
$152.00 |
| 90651 |
|
954 |
939 |
$75.00 |
| 90656 |
|
763 |
747 |
$70.88 |
| 90620 |
|
693 |
675 |
$62.00 |
| 90734 |
|
258 |
254 |
$2.00 |
| 96160 |
|
3,779 |
3,592 |
$2.00 |
| 90715 |
|
264 |
261 |
$1.00 |
| S9451 |
Exercise classes, non-physician provider, per session |
13,602 |
13,277 |
$1.00 |
| 90680 |
|
1,179 |
1,140 |
$0.01 |
| 90648 |
|
584 |
568 |
$0.00 |
| 90710 |
|
866 |
823 |
$0.00 |
| 90670 |
|
1,511 |
1,490 |
$0.00 |
| 90633 |
|
914 |
873 |
$0.00 |
| 90700 |
|
41 |
41 |
$0.00 |
| 91300 |
|
752 |
719 |
$0.00 |
| 91308 |
|
29 |
28 |
$0.00 |
| 90697 |
|
1,062 |
1,016 |
$0.00 |
| 90723 |
|
214 |
213 |
$0.00 |
| 90696 |
|
234 |
231 |
$0.00 |
| 91307 |
|
585 |
566 |
$0.00 |
| 90698 |
|
72 |
71 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
12 |
$0.00 |